RecruitingNot ApplicableNCT04932525
Gustave Roussy Cancer Profiling
Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Enrollment
20,000 participants
Start Date
May 10, 2021
Study Type
INTERVENTIONAL
Conditions
Summary
The objective of STING study is to perform high throughput molecular analysis (next generation sequencing +/- immunological profiling) to estimate the proportion of patients with cancer presenting at least one targetable genomic alteration.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Age ≥ 18 years
- Histology: solid malignant tumor or hematological malignancy.
- Patient with a social security in compliance with the French law relating to biomedical research (Article L.1121-11 of French Public Health Code)
- Voluntary signed and dated written informed consent prior to any study specific procedure.
Exclusion Criteria4
- Any condition which in the Investigator's opinion makes it undesirable for the subject to participate in a clinical trial or which would jeopardize compliance with the protocol
- Patient under guardianship or deprived of his liberty by a judicial or administrative decision or incapable of giving its consent
- Pregnant or breast-feeding women
- Minors (Age < 18 years)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREBiopsy
Blood and tumor samples for Genetic Profiling research
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04932525
Related Trials
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values
NCT049427175 locations
Phase 1/2a Study of MPB-1734 in Patients With Advanced Solid Tumors
NCT046434181 location
Psychotherapy Intervention for Latinos With Adv Cancer
NCT045379364 locations
Psychotherapy Intervention for Latinos With Advanced Cancer
NCT040156094 locations
AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors
NCT069113333 locations